annual operating profit:
-$577.37M+$22.08M(+3.68%)Summary
- As of today (May 29, 2025), BBIO annual operating income is -$577.37 million, with the most recent change of +$22.08 million (+3.68%) on December 31, 2024.
- During the last 3 years, BBIO annual operating profit has fallen by -$736.00 thousand (-0.13%).
- BBIO annual operating profit is now -1216.45% below its all-time high of -$43.86 million, reached on December 31, 2017.
Performance
BBIO Operating profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly operating profit:
-$103.80M+$117.53M(+53.10%)Summary
- As of today (May 29, 2025), BBIO quarterly operating income is -$103.80 million, with the most recent change of +$117.53 million (+53.10%) on March 31, 2025.
- Over the past year, BBIO quarterly operating profit has dropped by -$107.55 million (-2873.23%).
- BBIO quarterly operating profit is now -2873.23% below its all-time high of $3.74 million, reached on March 31, 2024.
Performance
BBIO quarterly operating profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM operating profit:
-$684.91M-$107.55M(-18.63%)Summary
- As of today (May 29, 2025), BBIO TTM operating income is -$684.91 million, with the most recent change of -$107.55 million (-18.63%) on March 31, 2025.
- Over the past year, BBIO TTM operating profit has dropped by -$212.01 million (-44.83%).
- BBIO TTM operating profit is now -1537.06% below its all-time high of -$41.84 million, reached on March 31, 2018.
Performance
BBIO TTM operating profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Operating profit Formula
Operating Profit = Gross Profit − Operating Expenses
BBIO Operating profit Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +3.7% | -2873.2% | -44.8% |
3 y3 years | -0.1% | +31.3% | -22.3% |
5 y5 years | -116.9% | -1.3% | -124.6% |
BBIO Operating profit Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -23.3% | +3.7% | -2873.2% | +53.1% | -55.6% | at low |
5 y | 5-year | -116.9% | +3.7% | -2873.2% | +53.1% | -124.6% | at low |
alltime | all time | -1216.5% | +3.7% | -2873.2% | +53.1% | -1537.1% | at low |
BBIO Operating profit History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2025 | - | -$103.80M(-53.1%) | -$684.91M(+18.6%) |
Dec 2024 | -$577.37M(-3.7%) | -$221.33M(+18.3%) | -$577.37M(+8.4%) |
Sep 2024 | - | -$187.13M(+8.4%) | -$532.70M(+5.9%) |
Jun 2024 | - | -$172.65M(-4712.6%) | -$502.99M(+6.4%) |
Mar 2024 | - | $3.74M(-102.1%) | -$472.91M(-21.1%) |
Dec 2023 | -$599.44M(+28.0%) | -$176.66M(+12.2%) | -$599.44M(+10.1%) |
Sep 2023 | - | -$157.42M(+10.4%) | -$544.32M(+6.5%) |
Jun 2023 | - | -$142.57M(+16.1%) | -$511.00M(+16.1%) |
Mar 2023 | - | -$122.79M(+1.0%) | -$440.21M(-6.0%) |
Dec 2022 | -$468.44M(-18.8%) | -$121.54M(-2.1%) | -$468.44M(-8.6%) |
Sep 2022 | - | -$124.10M(+72.9%) | -$512.51M(-4.7%) |
Jun 2022 | - | -$71.78M(-52.5%) | -$537.91M(-4.0%) |
Mar 2022 | - | -$151.02M(-8.8%) | -$560.14M(-2.9%) |
Dec 2021 | -$576.63M | -$165.61M(+10.8%) | -$576.63M(+7.1%) |
Sep 2021 | - | -$149.50M(+59.0%) | -$538.51M(+5.8%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Jun 2021 | - | -$94.02M(-43.9%) | -$508.95M(-5.7%) |
Mar 2021 | - | -$167.50M(+31.4%) | -$539.50M(+13.7%) |
Dec 2020 | -$474.48M(+78.2%) | -$127.49M(+6.3%) | -$474.48M(+11.5%) |
Sep 2020 | - | -$119.94M(-3.7%) | -$425.63M(+18.2%) |
Jun 2020 | - | -$124.57M(+21.5%) | -$360.22M(+18.1%) |
Mar 2020 | - | -$102.49M(+30.3%) | -$304.98M(+14.5%) |
Dec 2019 | -$266.24M(+45.0%) | -$78.64M(+44.2%) | -$266.24M(+5.2%) |
Sep 2019 | - | -$54.53M(-21.3%) | -$253.19M(+5.4%) |
Jun 2019 | - | -$69.32M(+8.7%) | -$240.11M(+16.8%) |
Mar 2019 | - | -$63.75M(-2.8%) | -$205.57M(+11.9%) |
Dec 2018 | -$183.66M(+318.8%) | -$65.58M(+58.2%) | -$183.66M(+55.5%) |
Sep 2018 | - | -$41.46M(+19.2%) | -$118.08M(+54.1%) |
Jun 2018 | - | -$34.78M(-16.9%) | -$76.62M(+83.1%) |
Mar 2018 | - | -$41.84M | -$41.84M |
Dec 2017 | -$43.86M | - | - |
FAQ
- What is BridgeBio Pharma annual operating income?
- What is the all time high annual operating profit for BridgeBio Pharma?
- What is BridgeBio Pharma annual operating profit year-on-year change?
- What is BridgeBio Pharma quarterly operating income?
- What is the all time high quarterly operating profit for BridgeBio Pharma?
- What is BridgeBio Pharma quarterly operating profit year-on-year change?
- What is BridgeBio Pharma TTM operating income?
- What is the all time high TTM operating profit for BridgeBio Pharma?
- What is BridgeBio Pharma TTM operating profit year-on-year change?
What is BridgeBio Pharma annual operating income?
The current annual operating profit of BBIO is -$577.37M
What is the all time high annual operating profit for BridgeBio Pharma?
BridgeBio Pharma all-time high annual operating income is -$43.86M
What is BridgeBio Pharma annual operating profit year-on-year change?
Over the past year, BBIO annual operating income has changed by +$22.08M (+3.68%)
What is BridgeBio Pharma quarterly operating income?
The current quarterly operating profit of BBIO is -$103.80M
What is the all time high quarterly operating profit for BridgeBio Pharma?
BridgeBio Pharma all-time high quarterly operating income is $3.74M
What is BridgeBio Pharma quarterly operating profit year-on-year change?
Over the past year, BBIO quarterly operating income has changed by -$107.55M (-2873.23%)
What is BridgeBio Pharma TTM operating income?
The current TTM operating profit of BBIO is -$684.91M
What is the all time high TTM operating profit for BridgeBio Pharma?
BridgeBio Pharma all-time high TTM operating income is -$41.84M
What is BridgeBio Pharma TTM operating profit year-on-year change?
Over the past year, BBIO TTM operating income has changed by -$212.01M (-44.83%)